top of page
Liquid Biopsies-PB5.png

Program

NOVEMBER 8th - Friday 

​8:30-8:40 AM

WELCOME & OPENING

​8:40-9:00 AM

EDUCATIONAL SESSION

Liquid biopsies: types, applications and perspectives in Oncology

Dr. Ludmilla Chinen - A. C. Camargo Cancer Center, São Paulo, Brazil            

9:00 - 10:10 AM

MAJOR SESSION: CIRCULATING TUMOR CELLS (CTCs)

Overview of CTCs: approaches, disease monitoring and early detection of cancer and use in clinical practice in Europe

Dr. Catherine Alix-Panabières - University of Montpellier, Montpellier, France

Circulating Tumor Cells in disease follow-up of patients with diverse solid tumors

Dr. Ludmilla Chinen - A.C. Camargo Cancer Center, São Paulo, Brazil

                                  

Discussion

​10:10-10:40 AM

COFFEE-BREAK & NETWORKING

​10:40-11:50 AM

MAJOR SESSION: EXOSOMES AS LIQUID BIOPSY

Detection of BRAFV600E mutation in lymphatic drainage-derived extracellular vesicles as prognostic factor and residual disease indicator in melanoma

Dr. Susana García-Silva – CNIO, Madrid, Spain

Liquid biopsies components as surrogates for cancer treatment response

Dr. Diana Noronha Nunes – A. C. Camargo Cancer Center, São Paulo, Brazil

Discussion

​11:50-12:40 PM

MAJOR SESSION: CIRCULATING NON-CODING RNAs

Circulating non-coding RNAs as tumor biomarkers

Dr. Miriam Galvonas Jasiulionis – Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil

 

Circulating microRNAs as potential biomarkers for early detection of lung cancer

Dr. Patrícia Pintor dos Reis – Universidade Estadual Paulista (UNESP), Botucatu, Brazil

 

Discussion

​12:40-2:30 PM

COMPLIMENTARY LUNCH

The growing relevance of liquid biopsy in clinical research: available technologies and recent advances 

Beatriz Pinto - Thermo Fisher Scientific, São Paulo, Brazil 

 

Discussion

​2:30-3:20 PM

MAJOR SESSION: CIRCULATING TUMOR DNAs (ctDNAs) - CLINICAL APPLICATIONS

Could circulating tumor DNA underpin the precision medicine?

Dr. Danielle Calcagno - Universidade Federal do Pará (UFPA), Belém, Brazil

                                  

The use of ctDNA in the clinical practice in lung cancer

Dr. Aknar Calabrich – Clínica AMO (Assistência Multidisciplinar em Oncologia), Salvador, Brazil

Discussion

3:20 - 4:00 PM

COFFEE-BREAK & NETWORKING

4:00-4:50 PM

MAJOR SESSION: CIRCULATING TUMOR DNAs (ctDNAs) - DETECTION AND CHALLENGES

 

ddPCR liquid biopsy’s impact on precision medicine

Dr. André Lavorato – Bio-Rad Laboratories, São Paulo, Brazil

Circulating Tumor DNA Assays in Clinical Diagnostic Tests

Dr. Elisa N. Ferreira – Grupo Fleury, São Paulo, Brazil

Discussion

4:50 - 5:00 PM

CLOSING REMARKS

OUR SPONSORS

AstraZeneca - logo.png
Eppendorf - logo.png
Agilent_Logo.png
Kasvi.png
ThermoFisher-logo2.png
Uniscience - logo2.png
Libbs-300x154.png
logo-pensabio-v2.png
bottom of page